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Allatostatin C modulates
nociception and immunity in
Drosophila
Nathaniel D. Bachtel1,2, Gary A. Hovsepian1,2, Douglas F. Nixon2 & Ioannis Eleftherianos1
Bacterial induced inflammatory responses cause pain through direct activation of nociceptive neurons,
and the ablation of these neurons leads to increased immune infiltration. In this study, we investigated
nociceptive-immune interactions in Drosophila and the role these interactions play during pathogenic
bacterial infection. After bacterial infection, we found robust upregulation of ligand-gated ion channels
and allatostatin receptors involved in nociception, which potentially leads to hyperalgesia. We further
found that Allatostatin-C Receptor 2 (AstC-R2) plays a crucial role in host survival during infection
with the pathogenic bacterium Photorhabdus luminescens. Upon examination of immune signaling
in AstC-R2 deficient mutants, we demonstrated that Allatostatin-C Receptor 2 specifically inhibits
the Immune deficiency pathway, and knockdown of AstC-R2 leads to overproduction of antimicrobial
peptides related to this pathway and decreased host survival. This study provides mechanistic insights
into the importance of microbe-nociceptor interactions during bacterial challenge. We posit that
Allatostatin C is an immunosuppressive substance released by nociceptors or Drosophila hemocytes
that dampens IMD signaling in order to either prevent immunopathology or to reduce unnecessary
metabolic cost after microbial stimulation. AstC-R2 also acts to dampen thermal nociception in
the absence of infection, suggesting an intrinsic neuronal role in mediating these processes during
homeostatic conditions. Further examination into the signaling mechanisms by which Allatostatin-C
alters immunity and nociception in Drosophila may reveal conserved pathways which can be utilized
towards therapeutically targeting inflammatory pain and chronic inflammation.
In recent years there has been a growing body of research investigating the role of the inflammatory response in
causing pain during bacterial infections including the discovery of interactions between bacteria, pain-sensing
neurons called nociceptors, primary sensory afferents and the innate immune system1. Upon activation by proinflammatory cytokines, bacterial lipopolysaccharides, flagella or a-hemolysin, specific ligand-gated ion channels
(TRPA1, FRPR1, ADAM10) open, resulting in an action potential propagating throughout these neurons2. Once
the synapse is reached, these nociceptors release various immunomodulatory neuropeptides into the proximal
vicinity including somatostatin, substance-P, CGRP and VIP3,4. These neuropeptides have been shown to have
a bimodal effect by altering further nociception, as well as having varied effects on inflammation. In fact, ablation of subcutaneous nociceptors has been shown to increase immune infiltration in mice during Staphylococcus
aureus infection whereas ablation near respiratory airways has been shown to reduce inflammation in a murine
asthma model1,5. Due to bacteria being able to directly activate these nociceptive neurons and many products of
these neurons altering systemic immunity, the question then arises as to whether the ability of bacteria to activate
nociceptive neurons is beneficial or detrimental to the host6.
The common fruit fly, Drosophila melanogaster, provides an excellent opportunity to investigate these interactions for numerous reasons. Drosophila is a well-established model for probing questions relating to the
innate immune response during microbial infection7–14. Moreover, Drosophila possesses primitive nociceptive
neurons that are able to respond to noxious temperatures, mechanical stimuli, as well as harmful chemicals
via sensory-gated ion channels15–17. Interestingly, these neurons can also be activated by the proinflammatory
cytokine, Eiger, and bacterially derived LPS, suggesting a greater degree of functional homology to mammalian
systems than previously realized18,19.
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Gene in Drosophila

Function

Human Ortholog

Allatostatin-A Receptor 1

Allatostatin A binding
Neuropeptide receptor activity
GPCR activity

Galanin receptor 2

Allatostatin-C Receptor 1

Allatostatin C binding
Neuropeptide receptor activity
GPCR activity

Somatostatin receptor 2

Allatostatin-C Receptor 2

Allatostatin C binding
Neuropeptide receptor activity
GPCR activity

Somatostatin receptor 2/4

Transient Receptor Potential
Cation Channel A1

Ligand gated cation channel activity Temperature gated channel activity

Transient Receptor Potential
Cation Channel A1

Pickpocket

Epithelial sodium channel
Noxious temperature and acid sensing activity

Acid sensing ion channel subunit 2

Cecropin A1

Antimicrobial peptide activity against gram-negative bacterium

N/A

Drosomycin

Antimicrobial peptide activity against gram-positive bacterium

N/A

Eiger

Tumor necrosis factor binding activity Inflammatory pain activity

TNF superfamily member 13b

Table 1. Immune and nociceptive related genes in Drosophila melanogaster probed in this study with their
corresponding functions and human homologs.
Activation of nociceptive neurons in Drosophila leads to an aversion to these noxious stimuli primarily
through avoidance behaviors20–24. Beyond this behavioral output, nociceptive neurons in Drosophila are also
linked with immune cell differentiation. RNAi knockdown of two genes crucial for nociceptor formation, painless
and piezo, has been shown to alter lamellocyte differentiation during parasitoid wasp infection, demonstrating
that nociceptor activation and cell-based immunity are linked in this invertebrate organism25.
The aim of the current study was to characterize a panel of known nociceptive (TRPA1, ppk, AstA-R1, AstC-R1,
AstC-R2) genes in Drosophila (Table 1), and to determine if any of these genes impacted survivorship or immune
function during bacterial infection. For this study, loss-of-function fly mutants for each gene were generated
and injected with either a non-pathogenic strain of E. coli or the insect-pathogenic bacterium P. luminecens.
Following infection, noxious heat threshold, survival, immune gene expression, and bacterial load in each mutant
were analyzed. Results showed that genes coding for TRPA1, ppk, AstA-R1, AstC-R1, and AstC-R2 are upregulated
during bacterial infection and this upregulation may lead to hyperalgesia. Interestingly, RNAi knockdown of
AstC-R2, a receptor for a neuropeptide hormone released from nociceptors that is homologous to mammalian
somatostatin (Supplementary Fig. 1), led to a significant decrease in fly survival during P. luminecens infection.
Further characterization of this gene’s role during infection with the pathogen suggests an immune deficiency
(IMD)-specific suppressive mechanism of action that, when removed, leads to an over-exuberant inflammatory
response and subsequently premature death. Our findings indicate that nociceptive-related genes are upregulated
during infection of Drosophila with insect pathogenic bacteria and that neuropeptides released from nociceptive
neurons play a significant role in the regulation of the host antibacterial immune response.

Results

Nociceptive-related genes are differentially upregulated in response to E. coli or P. luminescens.

Due to prior studies showing allodynia following UV radiation in Drosophila, we sought to determine whether
bacterial infection could also alter sensitivity to painful stimuli18. Hyperalgesia is the result of increased transcription and subsequent translation of ligand gated ion channels in nociceptive neurons26. Therefore, we determined
whether nociceptive-related genes, including TRPA1, ppk, AstA-R1, AstC-R1, and AstC-R2, were upregulated
during bacterial infection and whether the expression of these genes differed upon infection. We injected 7–10
day old wild-type flies with E. coli, P. luminescens, or PBS as a septic injury negative control, and monitored their
transcript level activity over the course of the infection.
Our results demonstrate that all five nociceptive genes were upregulated during infection with E. coli or P.
luminescens as compared to PBS. We found that nociceptive gene upregulation temporally differed between infections (Fig. 1). AstA-R1 expression was significantly upregulated (p = 0.0064) between 0 and 3 hours post infection with E. coli, before decreasing between 3 and 12 hours post infection (Fig. 1a). For P. luminescens, AstA-R1
expression peaked later during the infection, upregulated between 3 and 12 hours and 3 and 18 hours post infection (p = 0.0335 and p = 0.0063, respectively) (Fig. 1a). Transcript levels were higher in the E. coli infected flies
at 3 hours, in contrast to P. luminescens infected flies, which peaked at 18 hours. A similar pattern was seen for
transcript levels of AstC-R1, AstC-R2, TRPA1, and ppk (Fig. 1b–h).

Expression of nociception-related genes better correlates with bacterial load than with immune
induction. Upon attempting to correlate nociceptive gene transcript levels with bacterial load or immune

activation as measured by the induction of an antimicrobial peptide gene readout of the IMD pathway, Cecropin
A1, it was surprising to find that TRPA1, AstC-R1, and AstC-R2 expression significantly correlated with bacterial
load (p = 0.011, p = 0.047, p = 0.0246 respectively) (Fig. 2a) but not Cecropin A1 transcript levels (p = 0.358,
p = 0.329, p = 0.457 respectively) (Fig. 2b) during P. luminescens infection, suggesting bacteria may play an active
role in their induction. The same analysis with E. coli demonstrated that nociceptive gene transcript levels better
correlated with bacterial load (Supplementary Fig. 2a) than immune activation (Supplementary Fig. 2b), yet neither of these correlations were statistically significant (p > 0.05).
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Figure 1. Nociceptive gene expression in Drosophila differs temporally during bacterial infection. Expression of
(a) AstA-R1 (b) AstC-R1 (c) AstC-R2 (d) ppk (e) TRPA1 and (f) Cecropin A1 (CecA1) in Oregon flies responding
to non-pathogenic E. coli or pathogenic P. luminescens bacteria at 0, 3, 12, and 18 hours post infection. (g)
Upon infection with E. coli, all pain-related genes are upregulated at 3 hours and their mRNA levels decrease
to basal levels by 12 hours. (h) Upon P. luminescens infection nociceptive gene transcript levels increase to
a peak at either at 12 or 18 hours post infection. Differences in gene expression profiles were analyzed for
statistical significance using a student’s t-test (n = 3–4 groups of 10 flies per time point, *p < 0.05, **p < 0.01,
***p < 0.0001).

Drosophila IMD and TRPA1 RNAi mutants display hypoalgesia whereas AstC-R1 and AstC-R2
mutants display hyperalgesia. To better understand as to whether pain sensitization was linked to the

immune response or bacterial injection, we tested various immune and nociceptor Drosophila mutants using a
noxious heat escape assay to measure hypoalgesia and a withdrawal latency assay to measure hyperalgesia. The
noxious heat threshold of w1118 flies was a mean of 94% for the heat escape assay and these flies had a mean withdrawal latency of 7.7 seconds (Fig. 3a,b).
We determined that IMD knockdown mutants had a significantly increased pain threshold compared to
wild-type flies (mean = 83% vs 95%, p = 0.0003) (Fig. 3a). We found no significant changes in the pain threshold
of Toll 10b flies, a strain that constitutively expresses the Toll pathway (p = 0.99). Further, we found that the pain
threshold of IMD knockdown mutants was significantly decreased by injection of E. coli (83% vs 95%, p = 0.003)
(Fig. 3c), suggesting that IMD knockdown is not sufficient to abolish inflammatory pain in Drosophila.
TRPA1 knockdown mutants displayed a significantly increased pain threshold as compared to wild-type flies
(mean = 54% vs 94%, p < 0.0001) (Fig. 3a). This result is consistent with previous studies demonstrating the
importance of TRPA1 in sensing noxious temperatures26. We found a trend towards a decrease in the pain threshold of AstC-R1 knockdown mutants using the heat escape assay (mean = 98% vs 95%, p = 0.219) and a significant
decrease in withdrawal latency (mean = 8.4s vs 3.7s, p = 0.006). Similarly, we saw a trend in the pain threshold
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Figure 2. Allatostatin-C receptors and TRPA1 expression in Drosophila significantly correlates with bacterial
load during P. luminescens infection. Correlation and linear regression lines for nociceptive gene expression in
w1118 flies over time plotted against (a) bacterial load and (b) Cecropin A1 expression following P. luminescens
infection. Bacterial load significantly correlates with TRPA1, AstC-R1, and AstC-R2 expression upon infection
with P. luminescens via two-tailed linear regression analysis (n = 3–4 groups of 10 flies per time point, *p < 0.05).

of AstC-R2 knockdown mutants and wild-type flies (mean = 96% vs 95%, p = 0.86), while there was a significant
decrease in their withdrawal latency (mean = 8.4s vs 5.6s, p = 0.009) (Fig. 3a,b).

RNAi knockdown of AstC-R2 increases susceptibility to P. luminescens infection. Bacteria can
directly activate nociceptive neurons in Drosophila and the ablation of these neurons in mice alters immune infiltration1,18. We thus determined whether nociception-related genes are beneficial or detrimental to the host upon
bacterial infection. To test this, we generated RNAi knockdown mutants for each nociception-related gene and
measured the survival of flies over the course of infection with P. luminescens. Our results show that knockdown
of nociception-related genes had varying effects on the survival of the flies during bacterial infection (Fig. 4).
There was no significant change in survival of AstA-R1 knockdown mutants as compared to wild-type flies
during P. luminescens infection (p = 0.543) (Fig. 4a). In contrast, knockdown of AstC-R1 trended towards
a decrease in host survival whereas knockdown of AstC-R2 significantly reduced host survival (p = 0.0056)
(Fig. 4b). Although knockdown of AstC-R2 reduced survival during P. luminescens infection, it was not sufficient to change susceptibility to infection with a non-pathogenic strain of E. coli (p = 0.15) (Supplementary
Fig. 3a). Finally, knockdown of TRPA1, a known point of interaction between bacteria and host-nociceptor in
Drosophila, trended towards an increase in survival as compared to wild-type flies during P. luminescens infection
(p = 0.1872) (Fig. 4c).
RNAi knockdown of AstC-R2 hyperactivates the IMD pathway without reducing bacterial load.

Due to significant decrease in survival of AstC-R2 knockdown flies upon infection with P. luminescens, we sought
to determine whether alterations in NF-kB immune pathway activation and bacterial load in these flies could
explain this effect. We found a statistically significant hyperactivation of Cecropin A1 and Attacin A, two antimicrobial peptide readouts of the IMD pathway as compared to wild-type flies (Fig. 5a) at 12 and 18 hours post
infection with P. luminescens (CecA1: p = 0.0029, p = 0.0040, AttA: p = 0.048, p = 0.014 respectively). We saw
a similar hyperactivation in IMD signaling after infection by the non-pathogen, E. coli as well (Supplementary
Fig. 3b). However, transcript levels of Cecropin A1 did not differ between AstC-R2 RNAi knockdown flies and
wild-type flies in the absence of bacterial injection (Supplementary Fig. 4). Additionally, we observed a modest,
yet non-significant increased activation of the Toll pathway as measured by expression of Drosomycin at 18 hours
post infection (p = 0.15, Fig. 5b) and a slight decrease in Jak-Stat activation as measured by transcriptional expression of Eiger at 18 hours post infection (p = 0.09, Fig. 5c). Surprisingly, despite this robust increase in IMD signaling, we observed no statistically significant differences in the bacterial load in the AstC-R2 knockdown flies upon
P. luminescens infection at any timepoint (p > 0.05, Fig. 5d).

Discussion

During bacterial challenge, the host immune response must be mounted in a tightly regulated and quantitatively precise manner. Overproduction of immune effectors results in immune-related pathophysiology, tissue
damage, and metabolic cost whereas under-production of these effectors may permit bacterial expansion and
subsequently bacterially derived damage27–30. Recent studies have shown that bacteria can directly interact with
nociceptive neurons, and that ablation of these neurons leads to increased lymph drainage during S. aureus infection most likely by suppressing immunomodulatory neuropeptide release. Thus, bacterial activation of nociceptive neurons may be a novel mechanism of immune control. This study represents the first attempt to characterize
bacterially induced hyperalgesia and the effects of genes related to this process on host immunity in Drosophila
melanogaster. Our study provides support for a newly emerging idea that nociceptive neurons may be crucial to
mounting an appropriate immune response during these infections1,2,22.
We investigated the gene kinetics, effect on noxious behavior, and immune consequences of nociceptive gene
activation during microbial challenge. We found a robust upregulation of ligand gated ion channels (TRPA1 and
ppk) and Allatostatin receptors (AstC-R1, AstC-R2, AstA-R1) upon microbial challenge, the homologs of both
of which have been associated with hyperalgesia in mammalian systems31–37. We found that nociceptive gene
Scientific REPOrtS | (2018) 8:7501 | DOI:10.1038/s41598-018-25855-1
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Figure 3. Nociceptive and immune Drosophila mutants display alterations to pain sensing which can be
manipulated via bacterial challenge. (a) Noxious heat threshold of Drosophila RNAi mutants for nociceptive
and immune related genes. IMD RNAi mutants as well as TRPA1 mutants display a hypoalgesia whereas the
Toll 10b and AstC-R1 and AstC-R2 RNAi mutants do not display a reduced noxious heat sensing capacity.
(b) AstC-R2 and AstC-R1 RNAi mutants display reduced withdrawal latency. (c) IMD RNAi mutants display
hyperalgesia upon infection with E. coli but not upon PBS injection or in uninjected controls. RNAi mutants
were generated by crossing UAS-RNAi lines with an Actin5c Gal4 driver in order to knock the gene of interest
down ubiquitously. (−) Indicates the use of an RNAi line whereas (+) indicates a line that constitutively
expresses the gene of interest. Differences in noxious-related behaviors between Drosophila RNAi mutants
were analyzed for statistical significance using a student’s t-test (n = 3–9 groups of 20 female flies, *p < 0.05,
**p < 0.01, ***p < 0.0001).

activation differed temporally upon infection with E. coli as compared to pathogenic P. luminescens, and that
bacterial load better correlated with nociceptive gene activation than immune activation (as measured by the
IMD antimicrobial peptide encoding gene, Cecropin A1). Importantly, this correlation supports a recent paper
demonstrating that S. aureus bacterial load better correlates with hyperalgesia than paw swelling (immune infiltration) in mice1.
To determine whether the upregulation of these nociception-related genes contributed to hyperalgesia, we
generated immune and nociceptive knockdown fly mutants for the genes upregulated, and measured changes
to noxious heat sensitization. Upon examining alterations to this behavior, we found that AstC-R1 and AstC-R2
RNAi mutants displayed hyperalgesia whereas IMD and TRPA1 knockdown mutants showed robust hypoalgesia.
These results are in agreement with previous studies demonstrating the importance of TRPA1 in noxious heat
sensation38. To determine whether we could raise the noxious heat sensitivity of IMD mutants back to wild-type
levels by infection with a bacterium, we infected IMD knockdown flies with a non-pathogenic strain of E. coli and
found that these mutants displayed hyperalgesia, suggesting IMD activation contributes to, but is not necessary
for hyperalgesia during bacterial infections. These results implicate NF-kB activation as a conserved mechanism
of hyperalgesia in arthropod and mammalian lineages with the additional hyperalgesia seen upon infection of
IMD knockdown mutants being attributed to Toll signaling or direct bacterial activation39–41. Indeed, previous
studies have found that a transcription factor downstream of IMD activation, Relish, alters thermal nociception
as well17,22.
Due to bacteria being able to potentially manipulate the expression of nociceptive genes in their favor, we
were curious as to whether any of the nociception-related genes tested played a beneficial or detrimental role
to the host during microbial challenge. To test this, we silenced each nociception-related gene ubiquitously in
flies and measured their survival upon injection with the insect pathogen P. luminescens. We found a trend

Scientific REPOrtS | (2018) 8:7501 | DOI:10.1038/s41598-018-25855-1

5

www.nature.com/scientificreports/

Figure 4. Allatostatin-C Receptor Drosophila mutants show increased susceptibility to P. luminescens infection.
Survival curves of RNAi mutant flies for (a) AstA-R1 (b) AstC-R1 and AstC-R2 and (c) TRPA1 post injection
with PBS, P. luminescens, and E. coli. Although neither AstA-R1 and TRPA1 RNAi mutants displayed a reduced
survival during P. luminescens infection, AstC-R1 and AstC-R2 RNAi flies succumbed faster than their controls
with AstC-R2 RNAi individuals showing significantly increased sensitivity to the pathogen (p < 0.01). RNAi
mutants were generated by crossing UAS-RNAi lines with an Actin5c Gal4 driver in order to knock the gene
of interest down ubiquitously. Survival curves were analyzed using survival curve analysis in GraphPad Prism
software (n = 3 groups of 20 flies, **p < 0.01).

towards decreased survival of AstC-R1 knockdown flies and a significant decrease in survival upon knockdown
of AstC-R2, suggesting a potential role for Allatostatin-C in modulating host immune processes during bacterial
infection. However, when infecting AstC-R2 knockdown flies with the non-pathogen E. coli, we observed no
decreased survival over 48 hours hours as compared to wild-type flies suggesting that this effect alone is not sufficient to cause death.
The mammalian homolog of Allatostatin is Somatostatin42–44, which has documented effects in reducing systemic inflammation in mammalian systems, and thus we examined whether knockdown of AstC-R2 leads to
alterations in immune signaling that could contribute to the decreased survival4,45,46. We observed a robust over
induction of IMD signaling with a modest, but non-significant increase in Toll and decrease in Eiger as compared
to wild-type flies, suggesting that AstC-R2 reduced IMD signaling independently of the Toll or Jak-Stat pathways
respectively. Despite the robust upregulation of the IMD pathway, we observed no changes in bacterial load
during P. luminescens infection of AstC-R2 knockdown flies as compared to wild-type controls. These results
suggest that antimicrobial peptides related to this pathway are ineffective at controlling this pathogen. Indeed,
recent reports have shown that an antimicrobial peptide-resistant sub-population of P. luminescens is responsible
for the majority of the virulence during insect infection, and that P. luminescens is able to employ proteases that
specifically degrade antimicrobial peptides, rendering them post-translationally ineffective47,48.
By knocking down a receptor for Allatostatin C, which has dual role in inhibiting heat-driven nociception as
well as inhibiting the IMD pathway during bacterial challenge, we observed hyperactivation of this immune pathway, hyperalgesia, and reduced survival upon challenge with P. luminescens. The hyperalgesia seen in AstC-R1
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Figure 5. AstC-R2 RNAi Drosophila mutants display hyperactive IMD signaling without altered bacterial load.
Immune gene expression of AstC-R2 RNAi mutant and background control flies following infection with P.
luminescens bacteria. AstC-R2 RNAi mutant flies display (a) upregulation of the antimicrobial peptide-encoding
genes Cecropin A1 (CecA1) and Attacin A (AttaA) which are controlled by the IMD pathway with (b) a modest
increase in expression of the antimicrobial peptide-encoding gene Drosomycin (Drs) which is regulated by Toll
signaling, and (c) decrease in Eiger (egr) expression. (d) AstC-R2 flies demonstrate no significant decrease in
bacterial load over the course of P. luminescens infection. RNAi mutants were generated by crossing UAS-RNAi
lines with an Actin5c Gal4 driver in order to knock the gene of interest down ubiquitously. Differences in gene
expression profiles were analyzed for statistical significance using a student’s t-test (n = 2–5 groups of 10 flies
per time point per genotype, *p < 0.05, **p < 0.01).
and AstC-R2 RNAi knockdown flies in the absence of bacterial challenge most likely is not due to dysregulation
of the IMD pathway because we observed similar basal transcript levels of Cecropin A1 in AstC-R2 knockdown
mutants as compared to wild-type flies (Supplementary Fig. 3). Indeed, AstC-R1 and AstC-R2 also share structural homology with mammalian opioid receptors22. However, the reduced survival in AstC-R2 knockdown flies
may be explained either directly or indirectly by over activated IMD signaling and AstC-R2-IMD double knockdown mutants will be needed in order to confirm this hypothesis. Remarkably, our results recapitulate many of
the findings found in a seminal study investigating the importance of somatostatin receptor 4 in the modulation
of hyperalgesia and inflammation49. Therefore, Drosophila AstC-R2 may be more functionally similar to mammalian SSTR4 than previously perceived.
Due to the transcriptional upregulation of AstC-R1 and AstC-R2 during infection, it is likely that this upregulation reflects one mechanism of the host fine-tuning the immune response to prevent immune related damage
from occurring as well as mediating avoidance behaviors while in a compromised state. Somatostatin regulatory
circuits have been documented at sites of chronic inflammation where they have important roles in inhibiting
pro-inflammatory cytokine production by macrophages and T-cells yet found processes have not been previously
described in Drosophila50–53. Interestingly, another neuropeptide that acts as a crucial component of this circuit
by inhibiting somatostatin release is substance P, an additional molecule released from nociceptive neurons54,55.
Thus, immune manipulation during microbial challenge by nociceptive neurons is likely to be a well-orchestrated
process that amplifies or suppresses pro-inflammatory cytokine production in a way to best ensure host survival.
Our results imply that nociceptor-immune interactions during microbial infection in Drosophila may be
more similar to mammalian systems than previously conceived (Fig. 6). This idea is supported by recent findings
demonstrating that nociceptive neurons in flies are sensitive the proinflammatory cytokine Eiger, as well as bacterially derived lipopolysaccharides18,19. Drosophila also possesses homologous genes for other immuno-modulatory
substances released from nociceptors including substance P, CGRP and VIP (DTK, DH31, and Pdf respectively),
yet their roles in pain sensation and immunity have not been characterized56–58. Due to the wealth of transgenic
lines available, quick developmental cycle and cheap cost of maintenance, Drosophila could prove to be a valuable
tool in deciphering nociceptor-innate immune interactions in the future. Further studies into the interface of
Scientific REPOrtS | (2018) 8:7501 | DOI:10.1038/s41598-018-25855-1
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Figure 6. Potential role for AstC-R2 in nociceptor-bacterial-immune interactions in Drosophila. Upon
bacterial infection by a Gram-negative pathogen, the IMD pathway is activated by DAP-type peptidoglycan,
NF- κB is activated and translocates to the nucleus, and transcription of effector antimicrobial peptide-encoding
genes related to this pathway (CecA1) occurs. Simultaneously, TRPA1 channels open by direct interaction
with bacterial LPS or N-formyl peptides leading to nociceptive neuron firing and the subsequent release of
Allatostatin C. In turn, Allatostatin C inhibits the IMD pathway as well as heat driven nociception through
binding to AstC-R2 on the fat-body cells and nociceptors respectively, thus completing a negative regulatory
circuit controlling IMD activation. Figure was modified from images from Servier Medical Art, licensed under
a Creative Common Attribution 3.0 Generic License. http://smart.servier.com/.

pain, immunity, and microbial challenge hold large promise for innovative treatments for inflammatory pain,
auto-immune conditions, as well as potential explanations for host-tolerance of the gut microbiota.

Materials and Methods
Bacterial preparation.

Bacteria were stored as 20% glycerol stocks at −80 °C before use. Bacteria were
thawed and then grown in 10 mL of Luria-Bertani broth. Escherichia coli and Photorhabdus luminescens were
grown at 30 °C for 18 hours or 22 hours, respectively. After incubation, the bacterial solutions were pelleted by
centrifugation for 5 minutes at 4 °C at 3,000 rpm. The pellets were washed twice before resuspension in PBS.
Concentrations were adjusted using a Nanodrop 2000 spectrophotometer with an absorbance at 600 nm denoting
the respective concentrations. E. coli was used at an optical density (OD) of 0.015, while P. luminescens was used
at an OD of 0.10. This OD corresponds to between 300–1000 colony forming units (cfu) of each bacterium.

Drosophila mutants and crosses. The following Drosophila strains were obtained from the Vienna
Drosophila Resource Center (Vienna, Austria) or Exelixis at Harvard Medical School (Cambridge and
Massachusetts); Oregon and w1118, AstA-R1: v3400 and v3399, AstC-R1: v13560 and v110739, AstC-R2: v50000
and v106146, TRPA1: v37249 and v37250, ppk: v108683, Toll 10b and IMD (−), Actin5c-Gal4. UAS-RNAi
Drosophila lines were crossed with the Actin5C Gal4 driver in order to ubiquitously silence the gene of interest in
the resulting progeny. Reduced transcriptional activity of each gene silenced via-RNAi was confirmed via quantitative RT-PCR (qRT-PCR) (Supplementary Fig. 5).
Fly injection.

Drosophila melanogaster flies aged from 7–10 days were anesthetized using carbon dioxide.
10–12 flies were then injected with 18.4 nl of the standardized bacterial solution using a Nanoject microinjector
fitted with capillary needles. PBS was used as a septic injury negative control for all experiments. Flies were collected after injection by freezing at −80 °C.

Gene expression and bacterial load determination. RNA extractions were carried out using PrepEase
RNA Spin Kits (USB) or Trizol Reagent (Thermofisher) and eluted using molecular grade H2O. cDNA syntheses
were carried out using 300 ng of RNA with High Capacity Reverse Transcription cDNA Synthesis Kit (Applied
Scientific REPOrtS | (2018) 8:7501 | DOI:10.1038/s41598-018-25855-1
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Forward (5′-3′)

Reverse (5′-3′)

AstA-R1

CACGGCTACCGATTACGTGC

AAGGACATCAGCACCAGCGT

AstC-R1

GGTCCCAAACCAGGAACGAA

GAAATCCAGTGAGGGAGCCA

AstC-R2

CTGCCCGCAAGGATGTGA

TGTCGTCGTCGTTGTAGTGG

TRPA1

GACTTCGGGCGACAAGGAGA

CTCGCCCCACTGGAAGAAGA

ppk

AGCACGACCATTCACGGCATAC

CCAAAGTTCACTCACTGGGCATC

Cecropin A1

TCTTCGTTTTCGTCGCTCTC

CTTGTTGAGCGATTCCCAGT

Drosomycin

GACTTGTTCGCCCTCTTCG

CTTGCACACACGACGACAG

Eiger

AGCTGATCCCCCTGGTTTTG

GCCAGATCGTTAGTGCGAGA

Attacin A

CAATGGCAGACAATCTGG

ATTCCTGGGAAGTTGCTGTG

rp49

GATGACCATCCGCCCAGCA

CGGACCGACAGCTGCTTGGC

Table 2. Primers used in quantitative RT-PCR analysis of immune and nociception related genes in Drosophila
melanogaster.
Biosystems). The cDNA was then diluted 1/10 times before proceeding to qRT-PCR analysis. All qRT-PCR
assays were carried out using CFX96 Real-Time System (Bio-Rad). 1 µl of cDNA was used per reaction using
gene-specific primers (Table 2) (Eurofins MWG Operon) and SYBR Green Supermix (Bio-Rad). Ct values were
analyzed using the Delta Ct method using RpL32 as the control gene, and PBS as the control treatment. Bacterial
load was calculated using this method in conjunction with measuring the expression of 16S rRNA.

Noxious escape assays.

Twenty female flies between 7–10 days old were collected and placed in single
35 mm petri dish. These flies were left for 30 minutes to acclimate to their new environment. In order to determine
the noxious heat threshold, these flies were floated on a heat bath set at 42 °C for 55 seconds, and the noxious heat
threshold was determined by the percentage of flies that climbed to the top of the petri dish during this period of
time22. Each data point shown on Fig. 3a constitutes the mean of three technical replicates of one group of twenty
female flies.

Withdrawal latency assays. Twenty female flies between 7–10 days old were collected and placed in single
35 mm petri dish. These flies were left for 30 minutes to acclimate to their new environment. In order to determine
the withdrawal latency, these flies were floated on a heat bath set at 42 °C and the time it took for 75% of flies to
reach the top of the petri dish was measured22. Each data point shown on Fig. 3b constitutes the mean of three
technical replicates of one group of twenty female flies.
Statistical analyses. All statistical analyses, including student’s t-tests, two-tailed Pearson’s correlations, and
Log-Rank (Mantel-Cox) test survival curve analyses were performed using GraphPad Prism 6 software.

Statement of data availability. The datasets generated during and/or analyzed during the current study
are available from the corresponding author on reasonable request.
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